CIK 0001808805 · Non-accelerated filer<br>Smaller reporting company
Nautilus Biotechnology, Inc.
Sign in to watch- Ticker
- NAUT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981541723
- Phone
- 206-333-2001
- Business address
- 2701 EASTLAKE AVE EAST, SEATTLE, WA, 98102
- Former names
- ARYA Sciences Acquisition Corp III
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- 4 Derivatives Options or other derivatives
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- SC 13D Stake Beneficial Ownership Report
- D Other Notice of Sales of Unregistered Securities
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Former Director bought 5,507,063 shares at an average $10.00 ($55,070,983)
- 4 Conversion Director acquired 499,000 shares (conversion)
- 8-K Event Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Shell status change
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 13 of 17 · 328 filings